Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study)
- PMID: 3162108
- DOI: 10.1159/000118159
Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study)
Abstract
21 depressed patients of the Basle University Psychiatric Outpatient Clinic were treated in a double-blind study with paroxetine and amitriptyline. 11 of these patients did not continue the trial until the end of the 7th week. There was a significant difference in the number of dropouts between the two groups: 80% of the amitriptyline group did not continue until the end, while in the paroxetine group we found only 30% dropouts. The patients of both groups showed a gradual decrease of the median total scores on the Hamilton and the Montgomery and Asberg Depression Rating Scales. Although the number of patients who stayed in the trial for at least 4 weeks (8 with paroxetine, 6 with amitriptyline) is quite small, we see from the results of the clinical global impression that the members of the paroxetine group improved most of all in the somatic symptoms, while considering their moods we found no differences between the groups. Patients of both groups complained about side effects, most of all about dry mouth and tiredness. From the high rate of dropouts under amitriptyline we found that the side effects under this drug were more severe and therefore led to the dropouts.
Similar articles
-
A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group.Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:37-41. doi: 10.1097/00004850-199206004-00008. Int Clin Psychopharmacol. 1992. PMID: 1431009 Clinical Trial.
-
A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.J Clin Psychopharmacol. 1994 Aug;14(4):241-6. J Clin Psychopharmacol. 1994. PMID: 7962679 Clinical Trial.
-
Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.Pharmacopsychiatry. 1993 May;26(3):75-8. doi: 10.1055/s-2007-1014346. Pharmacopsychiatry. 1993. PMID: 8415897 Clinical Trial.
-
Paroxetine in the treatment of depression--a randomized comparison with amitriptyline.Acta Psychiatr Scand. 1985 Mar;71(3):249-55. doi: 10.1111/j.1600-0447.1985.tb01281.x. Acta Psychiatr Scand. 1985. PMID: 3157296 Clinical Trial.
-
A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.Acta Psychiatr Scand Suppl. 1989;350:145-6. doi: 10.1111/j.1600-0447.1989.tb07198.x. Acta Psychiatr Scand Suppl. 1989. PMID: 2530773 Clinical Trial. No abstract available.
Cited by
-
Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.Psychopharmacology (Berl). 1987;93(2):193-200. doi: 10.1007/BF00179933. Psychopharmacology (Berl). 1987. PMID: 2962217
-
Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.CMAJ. 1998 Nov 17;159(10):1245-52. CMAJ. 1998. PMID: 9861221 Free PMC article.
-
Amitriptyline for depression.Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004186. doi: 10.1002/14651858.CD004186.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636748 Free PMC article.
-
Cardiovascular effects of paroxetine.Psychopharmacology (Berl). 1990;102(3):379-82. doi: 10.1007/BF02244107. Psychopharmacology (Berl). 1990. PMID: 2147517 Clinical Trial.
-
Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.BMJ. 1995 Jun 3;310(6992):1433-8. doi: 10.1136/bmj.310.6992.1433. BMJ. 1995. PMID: 7613276 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources